Baidu
map

Clin J Am Soc Nephrol:在维持性血液透析患者(MHD)中,高个子更易死亡?

2015-04-21 徐媛媛译 MedSci原创

身体质量指数(BMI)是用体重公斤数除以身高米数平方得出的数字,BMI与接受血透患者的死亡率呈负相关。然而,几乎没有数据显示MHD患者身高与死亡率之间的关系。本文研究了在MHD患者中身高与死亡率之间的联系。 我们进行了一项前瞻性研究才,此项研究开始于2001年7月1日,该研究纳入117644例MHD患者,患者信息包括(1)身高和体重,(2)年龄≥18年,(3)透析时间≥90天,和(4)相关BMI

身体质量指数(BMI)是用体重公斤数除以身高米数平方得出的数字,BMI与接受血透患者的死亡率呈负相关。然而,几乎没有数据显示MHD患者身高与死亡率之间的关系。本文研究了在MHD患者中身高与死亡率之间的联系。

我们进行了一项前瞻性研究才,此项研究开始于2001年7月1日,该研究纳入117644例MHD患者,患者信息包括(1)身高和体重,(2)年龄≥18年,(3)透析时间≥90天,和(4)相关BMI值(≥12到≤60 kg / m2)。随访时间截止到2007年6月30日,中位随访时间为852天(范围:504-1367天)。通过校正模型,使用风险比(HR)来计算身高体重与死亡率之间关系,结果包括全因死亡率和心血管、感染和肿瘤死亡率

在收纳的117644例MHD患者中,患者的平均年龄为61±15岁,45%为女性,57%患有糖尿病。在校正模型中,

该前瞻性研究纳入117644例MHD患者,中位随访时间为852天。以了解此类患者的身高与死亡率间的关系,并评估身高对BMI-死亡率关系的影响。身高(经体重校正后)与全因死亡率和心血管、感染和肿瘤死亡率直接相关。与身高在中位水平的患者相比,身高在最高等分位的死亡风险是1.18(95% CI,1.14-1.23)(P < 0.001)。通过特性曲线分析表明,在调整分析后,身高对BMI和死亡率间关系的作用几乎等同于体重。

原始出处

Shapiro BB1, Streja E2, Ravel VA2, Kalantar-Zadeh K3, Kopple JD4.Association of Height with Mortality in Patients Undergoing Maintenance Hemodialysis.Clin J Am Soc Nephrol. 2015 Mar 30

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2057556, encodeId=b3b1205e556e1, content=<a href='/topic/show?id=77f1116e486' target=_blank style='color:#2F92EE;'>#MHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11674, encryptionId=77f1116e486, topicName=MHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Feb 22 11:15:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33733, encodeId=267533e33c4, content=屌丝的福利么, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 10:47:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262460, encodeId=8ad712624607f, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570581, encodeId=edce15e058192, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=)]
    2016-02-22 xugumin
  2. [GetPortalCommentsPageByObjectIdResponse(id=2057556, encodeId=b3b1205e556e1, content=<a href='/topic/show?id=77f1116e486' target=_blank style='color:#2F92EE;'>#MHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11674, encryptionId=77f1116e486, topicName=MHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Feb 22 11:15:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33733, encodeId=267533e33c4, content=屌丝的福利么, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 10:47:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262460, encodeId=8ad712624607f, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570581, encodeId=edce15e058192, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=)]
    2015-07-29 sundong

    屌丝的福利么

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2057556, encodeId=b3b1205e556e1, content=<a href='/topic/show?id=77f1116e486' target=_blank style='color:#2F92EE;'>#MHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11674, encryptionId=77f1116e486, topicName=MHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Feb 22 11:15:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33733, encodeId=267533e33c4, content=屌丝的福利么, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 10:47:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262460, encodeId=8ad712624607f, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570581, encodeId=edce15e058192, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=)]
    2015-04-23 habb
  4. [GetPortalCommentsPageByObjectIdResponse(id=2057556, encodeId=b3b1205e556e1, content=<a href='/topic/show?id=77f1116e486' target=_blank style='color:#2F92EE;'>#MHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11674, encryptionId=77f1116e486, topicName=MHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Feb 22 11:15:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33733, encodeId=267533e33c4, content=屌丝的福利么, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 10:47:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262460, encodeId=8ad712624607f, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570581, encodeId=edce15e058192, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Thu Apr 23 06:15:00 CST 2015, time=2015-04-23, status=1, ipAttribution=)]

相关资讯

高通量透析器利于改善MHD者贫血

 最近,首都医科大学附属北京友谊医院肾内科的研究人员的一项研究显示,高通量聚醚砜膜(high-flux ployethersulfone,PES)膜和三醋酸纤维素膜(high-flux cellulose triacetate,CTA)膜改善维持性血液透析(maintenance hemodialysis ,MHD)患者贫血治疗的效果优于低通量聚砜膜(Polysulfone,PS)膜和聚甲基丙烯酸

MHD常并发肺动脉高压

  最近,中国医学科学院北京协和医学院北京协和医院肾内科、心内科的研究人员的一项研究显示,肺动脉高压(PHT)是维持性血液透析(MHD)常见的并发症,其发生与左室收缩和舒张功能下降密切相关;与钙磷代谢、动静脉内瘘(AVF)流量、血红蛋白、透析充分性及营养状态等无明显相关性。该研究发表于2012年第1期《中华肾脏病杂志》。   该研究旨在研究长期维持性血液透析患者PHT的特征及相关因素。

Baidu
map
Baidu
map
Baidu
map